Cited by 4,558Nanotechnology research and applicationsNanoparticle-Based Drug DeliveryNanoplatforms for cancer theranostics

Cancer nanotechnology: opportunities and challenges

Ferrari, Mauro·2005·Nature Reviews Cancer

Abstract

Nanotechnology is a multidisciplinary field, which covers a vast and diverse array of devices derived from engineering, biology, physics and chemistry. These devices include nanovectors for the targeted delivery of anticancer drugs and imaging contrast agents. Nanowires and nanocantilever arrays are among the leading approaches under development for the early detection of precancerous and malignant lesions from biological fluids. These and other nanodevices can provide essential breakthroughs in the fight against cancer.

Integrity signals

Registry

Crossref · 10.1038/nrc1566

Cites

133 of 133 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Targeted therapy is the combination of targeted delivery with sustained drug release, which allows maximum utilization of the drug delivered at the tumor site.

    “Targeted therapy is thus the combination of targeted delivery with sustained drug release, which allows the maximum utilization of the drug delivered at the tumor site.236”

Cites

Flagged first, then by citations

2 of the 135 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Ferrari, M.
Venue
Nature Reviews Cancer
Published
2005-03-01
Volume
5
Issue
3
Pages
161-171
ISSN
  • 1474-175X (ISSN-L)
  • 1474-1768
OpenAlex
W1989195046
Cited by
4,558
References
135
Citations by year
2026: 60 · 2025: 99 · 2024: 137 · 2023: 181 · 2022: 157 · 2021: 191 · 2020: 221 · 2019: 240 · 2018: 257 · 2017: 291 · 2016: 287 · 2015: 297 · 2014: 328 · 2013: 367 · 2012: 294
FWCI
13.96
Type
journal article
Language
en
Open access
closed
Locations
  • Nature reviews. Cancer (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › Nanotechnology research and applications
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
Keywords
cancer nanotechnology, nanovectors, targeted drug delivery, anticancer agents, imaging contrast agents, nanowires, early cancer detection, precancerous lesions, biological fluids
MeSH terms
Antineoplastic Agents, Contrast Media, Diagnosis, Differential, Equipment Design, Humans, Neoplasms, Nanotechnology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review